Your browser doesn't support javascript.
loading
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
Wu, Yiming; Jin, Meiling; Fernandez, Mike; Hart, Kevyn L; Liao, Aijun; Ge, Xinzhou; Fernandes, Stacey M; McDonald, Tinisha; Chen, Zhenhua; Röth, Daniel; Ghoda, Lucy Y; Marcucci, Guido; Kalkum, Markus; Pillai, Raju K; Danilov, Alexey V; Li, Jingyi Jessica; Chen, Jianjun; Brown, Jennifer R; Rosen, Steven T; Siddiqi, Tanya; Wang, Lili.
Afiliación
  • Wu Y; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Jin M; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Fernandez M; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Hart KL; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Liao A; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Ge X; Department of Statistics, University of California, Los Angeles, California.
  • Fernandes SM; Department of Computational Medicine, University of California, Los Angeles, California.
  • McDonald T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chen Z; The Hematopoietic Tissue Biorepository, City of Hope National Comprehensive Cancer Center, Duarte, California.
  • Röth D; Department of Hematological Malignancies Translational Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Ghoda LY; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California.
  • Marcucci G; Department of Molecular Imaging and Therapy, Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California.
  • Kalkum M; The Hematopoietic Tissue Biorepository, City of Hope National Comprehensive Cancer Center, Duarte, California.
  • Pillai RK; Department of Hematological Malignancies Translational Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Danilov AV; The Hematopoietic Tissue Biorepository, City of Hope National Comprehensive Cancer Center, Duarte, California.
  • Li JJ; Department of Hematological Malignancies Translational Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Chen J; Department of Hematology & Hemato-poietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Brown JR; Department of Molecular Imaging and Therapy, Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California.
  • Rosen ST; Department of Pathology, City of Hope National Comprehensive Cancer Center, Duarte, California.
  • Siddiqi T; Department of Hematology & Hemato-poietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Wang L; Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California.
Blood Cancer Discov ; 4(3): 228-245, 2023 05 01.
Article en En | MEDLINE | ID: mdl-37067905
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Empalme Alternativo Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Empalme Alternativo Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos